Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TMO | US
3.01
0.64%
Healthcare
Diagnostics & Research
30/06/2024
24/04/2026
469.71
469.15
475.00
464.65
Thermo Fisher Scientific Inc. provides life sciences solutions analytical instruments specialty diagnostics and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents instruments and consumables for biological and medical research discovery and production of drugs and vaccines as well as diagnosis of infections and diseases; and solutions include biosciences genetic sciences clinical next-generation sequencing bio production to pharmaceutical biotechnology agricultural clinical healthcare academic and government markets. Its Analytical Instruments segment provides instruments consumables software and services for use in laboratory on production line and in field for pharmaceutical biotechnology academic government environmental and other research and industrial markets as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid ready-to-use and lyophilized immunodiagnostic reagent kits as well as calibrators controls and calibration verification fluids; immunodiagnostics develops manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy asthma and autoimmune diseases; dehydrated and prepared culture media collection and transport systems instrumentation and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products laboratory chemicals research and safety market channel and pharma services and clinical research. The company offers products and services through a direct sales force customer-service professionals electronic commerce third-party distributors and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham Massachusetts.
View LessStrength based on increasing price with high volume
Low 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Price Below SMA10D
High Short-term Volatility
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
55.1%1 month
42.5%3 months
33.0%6 months
27.6%37.33
25.00
4.83
0.75
0.36
21.94
6.03
2.23
10.76B
179.43B
179.43B
0.26
17.40
15.10
-1.40
13.53
2.67
0.90
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
82.80
Range1M
82.80
Range3M
183.59
Rel. volume
1.34
Price X volume
1.13B
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Danaher Corporation | DHR | Diagnostics & Research | 177.25 | 128.01B | -0.74% | 50.44 | 36.50% |
| IDEXX Laboratories Inc | IDXX | Diagnostics & Research | 565.93 | 46.58B | 0.89% | 45.46 | 67.58% |
| Agilent Technologies Inc | A | Diagnostics & Research | 115.55 | 33.20B | 0.99% | 28.92 | 49.67% |
| IQVIA Holdings Inc | IQV | Diagnostics & Research | 162.28 | 29.58B | 1.00% | 30.78 | 200.33% |
| Mettler-Toledo International Inc | MTD | Diagnostics & Research | 1282.45 | 27.21B | 1.43% | 37.74 | -1347.12% |
| Koninklijke Philips N.V | PHG | Diagnostics & Research | 27.47 | 25.60B | -0.58% | n/a | 69.56% |
| Natera Inc | NTRA | Diagnostics & Research | 203.75 | 25.20B | 1.30% | n/a | 52.31% |
| DexCom Inc | DXCM | Diagnostics & Research | 61.57 | 24.67B | -1.80% | 44.96 | 106.57% |
| Laboratory Corporation of America Holdings | LH | Diagnostics & Research | 263.8 | 22.15B | -0.42% | 40.18 | 74.63% |
| Quest Diagnostics Incorporated | DGX | Diagnostics & Research | 196.27 | 21.85B | -1.63% | 20.22 | 76.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| The Walt Disney Company | DIS | Media - Diversified | 102.6 | 186.07B | -1.01% | 37.27 | 47.29% |
| Carrier Global Corporation | CARR | Building Products & Equipment | 60.97 | 55.04B | -0.93% | 21.69 | 100.40% |
| Netflix Inc | NFLX | Media - Diversified | 92.44 | 39.67B | -0.41% | 43.23 | 70.34% |
| Live Nation Entertainment Inc | LYV | Media - Diversified | 156.64 | 36.36B | 2.24% | 105.45 | -18562.20% |
| PPL Corporation | PPL | Building Products & Equipment | 38.75 | 28.59B | 0.54% | 28.90 | 114.80% |
| Twenty-First Century Fox Inc | FOXA | Media - Diversified | 62.85 | 27.58B | -2.60% | 13.57 | 76.09% |
| Twenty-First Century Fox Inc | FOX | Media - Diversified | 56.17 | 26.86B | -2.72% | 12.45 | 76.09% |
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| Dolby Laboratories Inc | DLB | Media - Diversified | 64.08 | 6.11B | 1.78% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 21.94 | 12.67 | Expensive |
| Ent. to Revenue | 6.03 | 44.00 | Cheaper |
| PE Ratio | 37.33 | 40.09 | Par |
| Price to Book | 4.83 | 77.50 | Cheaper |
| Dividend Yield | 0.26 | 1.18 | Poor |
| Std. Deviation (3M) | 33.01 | 59.59 | Lower Risk |
| Debt to Equity | 0.75 | -14.36 | Expensive |
| Debt to Assets | 0.36 | 0.34 | Par |
| Market Cap | 179.43B | 13.71B | Market Leader |